ATOS - Atossa Genetics Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
0
0
0
0
2
Cost of Revenue
-
-
-
0
132
Gross Profit
-
-
-
0
-131
Operating Expenses
Research Development
6,597
4,210
2,328
770
2,360
Selling General and Administrative
10,159
7,224
4,859
6,479
10,268
Total Operating Expenses
16,756
11,434
7,187
7,250
12,628
Operating Income or Loss
-16,756
-11,434
-7,187
-7,250
-12,759
Interest Expense
-
-
193
-
-
Total Other Income/Expenses Net
56
29
-935
881
0
Income Before Tax
-16,700
-11,405
-8,123
-6,369
-12,758
Income Tax Expense
-
-
-
0
-
Income from Continuing Operations
-16,700
-11,405
-8,123
-6,369
-12,758
Net Income
-16,700
-11,405
-8,123
-6,369
-15,760
Net Income available to common shareholders
-16,700
-22,884
-10,691
-6,369
-15,760
Reported EPS
Basic
-
-5.50
-10.92
-33.60
-99.00
Diluted
-
-5.50
-10.92
-33.60
-99.00
Weighted average shares outstanding
Basic
-
4,158
975
190
158
Diluted
-
4,158
975
190
158
EBITDA
-
-11,390
-7,187
-6,946
-12,486